findmyKOL
Clinical trialNCT03603808CompletedPhase 2Interventional

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

SponsorAIDS Malignancy ConsortiumEnrollment44Anal Intraepithelial NeoplasiaHIV PositivityHigh Grade Squamous Intraepithelial NeoplasiaHuman Papillomavirus-16 PositiveHuman Papillomavirus-18 Positive
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • University of Puerto Rico

    San Juan, Puerto Rico

United States
  • University of California, San Francisco

    San Francisco, California, United States

  • Grady Health System

    Atlanta, Georgia, United States

  • Anal Dysplasia Clinic Midwest

    Chicago, Illinois, United States

  • Boston Medical Center

    Boston, Massachusetts, United States

  • Laser Surgery Care

    New York, New York, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • Wake Forest Baptist Health Sciences

    Winston-Salem, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Sept 2018
Primary completion
31 Dec 2024
Completion
17 Jun 2025
Last update posted
8 Jul 2026
Registered enrollment
44
Registry id
NCT03603808

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.